Navigation Links
Pain Doctor in Virginia Sentenced to Five Years Imprisonment

A pain-management doctor who prescribed huge quantity of opiates to patients at his northern Virginia clinic was sentenced Friday to nearly five years in prison on federal drug charges.

Thats more time than his supporters and some of the jurors were hoping for, but its still a major victory for him and for the scientists who testified at the trial. The prosecutors had asked for a life sentence. Prosecutors argued that Hurwitz reaped hundreds of thousands of dollars from an illegitimate medical practice.

The sentence is a distinct reduction from the 25-year sentence Dr. Hurwitz was serving after being convicted in 2004 on drug trafficking and other charges. (The conviction was overturned and resulted in a retrial, at which he was convicted of 16 counts of drug trafficking.) One of Dr. Hurwitzs lawyers, Richard Sauber, said that, considering the time already served, Dr. Hurwitz could be free in 17 months.

Authorities claimed Hurwitz crossed the line from doctor to illegitimate medical practice .

U.S. District Judge Leonie Brinkema faulted Hurwitz for ignoring clear signals that some of his patients were obvious drug dealers or abusers, but she also credited him with saving lives with his willingness to prescribe the drugs to patients with debilitating pain.

The judge defended the bulk of Hurwitz's practice as legitimate medicine that saved patients' lives. She said medical literature has increasingly come to support Hurwitz's theories about the propriety of massive drug doses for patients in chronic pain.

William E. Hurwitzs 61, pain-management clinic in a suburb of Washington, D.C., drew patients from across the country. Hurwitz was one of the most outspoken doctors in the United States advocating liberal use of opiates for pain treatment, once appearing on television talk show to tout his views. He said many doctors under treat pain because they ignore patient complaints or they are fearful
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Indian Doctor granted US patent on organ regeneration
7. Emphasis to ban Drugs ads by Doctors
8. Doctor samples come under the ambit of advertisement
9. Doctors not to accept gifts from drug companies
10. Gene testing kit specific for Doctors
11. Doctors warned of fluoride toxicity

Post Your Comments:
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...ngual coloring books designed for children ages 2 ...to educate - inform parents and children alike on ...ars to ABC,S and a host of other topics. , ... 27, 2009 -- Today’s children have enough ga...our of the day, but one of the oldest and simplest...
(Date:11/26/2009)...wswire/ -- The diabetes population in the United S...d annual medical spending on the disease is projec...y, according to a study published in the December ...Diabetes ® Program (NCDP), a program of Novo ...the University of Chicago. ,, According to the ...
(Date:11/26/2009)...l rollercoaster, study finds , , THURSDA...ctor meets the jubilant sports fan. , A new stu...o root for the winning team -- enjoy the greatest ... victory was in doubt, producing feelings of worry...ving weekend as you,re glued to the TV set, watchi...
(Date:11/26/2009)...ons announces a highly effective and unconventiona...to make an economic recovery. , ...he type of challenge that could send ailing holida...vid Benton, business growth expert and author of t...The Rfactor Intensive . “Fear is one of th...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...herapies Will Launch Over Next Decade, According t...LTHAM, Mass., Dec. 2 Decision Resources, one of t... pharmaceutical and healthcare issues, finds that ...o the new special report entitled Cellular Therap...
...ated Psoriasis Patients Will Double by 2017, Accor..., WALTHAM, Mass., Dec. 2 Decision Resources, on...ms for pharmaceutical and healthcare issues, finds...t to more than double to nearly $5 billion over th...
...Inc. (NYSE: MYL ) today,announced that it and it...ered,into a settlement agreement with Novartis Pha...ternational AG related to Letrozole Tablets, the g...ement, which demonstrates our ability to once,agai...
...ec. 2 TYRX, Inc., a leader in the development and...cts, today announced the appointment of David Elli...r commercial operations. , , Mr. Elliot bring...ser-based antimicrobial and vascular plaque destru...
...orm an integral part of most of,original equipment... become,essential for service providers in the Eur...mpetitive and constantly improve their services an...http://www.medicalimaging.frost.com ),European Med...
... Xena Health and Solutions Medical Billing Team Up...aims in a Cloud" as a SaaS Application. , ...ecember 2, 2008 -- Making medical insurance claims... Modelling partners Xena Health and Solutions Medi...
Other Medicine News:Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2Health News:Biologic Drugs, Particularly Centocor/Janssen-Cilag's Stelara and Abbott/Eisai's Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017 2Health News:Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Corporate Modelling Partners Start Selling BPM in Cloud Service 2
(Date:11/25/2009)..., PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/...stage pharmaceutical company committed to discover... treat viral infections, reported financial result... September 30, 2009 Pharmasset held $58.4 million ...ts. ,, Pipeline Update and 2009 Highlights ,...
(Date:11/25/2009)..., CHICAGO and STAFA, Switzerland, Nov. 25 /PRNewsw...manufacturer of innovative hearing solutions, pres...dults Conference, focusing on the special needs of...ther leading experts in aging and audiology from a...ork everyday with older people with hearing loss f...
(Date:11/25/2009)... BRIDGEWATER, N.J., Nov. 25 The FD... (etravirine) tablets, a non-nucleoside reverse tr...ly NNRTI specifically indicated for use in treatme...ic failure with HIV-1 strains resistant to an NNRT...itional approval is based on 48-week data from two...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Soy in the Diet May Protect Lung Function 50201 1The Psychology of Celebrity Worship 50198 1The Psychology of Celebrity Worship 50198 2The Psychology of Celebrity Worship 50198 3CareFusion Names Robert Friel to Board of Directors 50196 1CareFusion Names Robert Friel to Board of Directors 50196 2CareFusion Names Robert Friel to Board of Directors 50196 3
...ta from two Phase 3 trials show clinical success r...ibiotic therapy, WELLESLEY HILLS, Mass., March 13... announced today the presentation of,a poster enti...y for,Treating Infected Diabetic Foot Ulcers: A Ra...rial of Pexiganan Cream." The poster will be,prese...
...S, March 12 Eli Lilly and Company,(NYSE: LLY ), ...mpany,practices as alleged by the Connecticut Atto...issued March 11, 2008., The tone and content of t...rently be taking Zyprexa to treat a life-threateni...ed no acknowledgement of the,seriousness of schizo...
Other Medicine Technology:MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 2MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 3MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 4MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 5Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 2Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 3Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: